期刊文献+

HBV相关慢加急性肝衰竭患者血清细胞因子水平与疾病预后的关系研究 被引量:26

Research on the relationship between serum cytokine levels and prognosis in patients with HBV-related acute-on-chronic liver failure
暂未订购
导出
摘要 目的观察乙型肝炎病毒(HBV)相关慢加急性肝衰竭(ACLF)患者血清细胞因子水平的变化,探讨细胞因子在疾病预后中的作用。方法收集HBV相关ACLF患者24例(治愈者13例,死亡者11例)、慢性乙型肝炎(CHB)患者30例和正常对照者15名,采用Luminex液相芯片技术检测血清白细胞介素IL-2、IL-4、IL-6、IL-8、IL-10、粒细胞-巨噬细胞刺激因子(GM-CSF)、γ干扰素(IFN-γ)和肿瘤坏死因子α(TNF-α)等细胞因子水平,并结合临床指标进行相关分析。结果 ACLF组IL-6、IL-8和TNF-α水平高于CHB组和对照组(P<0.01),CHB组亦高于对照组(P<0.05);ACLF死亡组IL-6、TNF-α水平和终末期肝病模型(MELD)评分明显高于治愈组(P<0.05);TNF-α、IL-6与凝血酶原活动度(PTA)之间呈明显负相关(r=-0.712,P<0.001;r=-0.521,P=0.009);TNF-α、IL-6与MELD评分之间呈明显正相关(r=0.491,P<0.015;r=0.379,P=0.048)。细胞因子与HBV DNA和乙型肝炎表面抗原(HBsAg)之间无明显相关性。结论 HBV相关ACLF患者血清中多种细胞因子明显升高,其中IL-6和TNF-α水平随疾病严重程度的增加而增加,检测其血清细胞因子水平有助于疾病严重程度和预后转归的判断。 Objective To observe the changes of serum cytokine levels in patients with hepatitis B virus (HBV) - related acute-on-chronic liver failure ( ACLF ) , and investigate the role of cytokines in the prognosis of HBV-related ACLF. Methods A total of 24 HBV-related ACLF patients (13 cured cases and 11 dead cases), 30 patients with chronic hepatitis B(CHB) and 15 healthy controls were enrolled. The serum levels of interleukin( IL)-2, IL-4, IL-6, IL-8, IL-10, granulocyte-macrophage colony stimulating factor (GM-CSF) , gamma interferon (IFN-γ) and tumor necrosis factor alpha(TNF-α) were detected by Luminex liquid chip technology, and the relative results were analyzed. Results The levels of IL-6, IL-8 and TNF-α in ACLF group were higher than those in CHB group and healthy control group ( P 〈 0.01 ), and those in CHB group were higher than those in healthy control group ( P 〈 0.05 ). IL-6, TNF-α and model for end stage liver disease (MELD) score in ACLF dead group were significantly higher than those in ACLF cured group( P 〈0.05). The levels of TNF-α and IL-6 were negatively correlated with prothrombin activity(PTA) (r = -0. 712, P 〈0. 001 ; r = -0. 521, P =0. 009). Furthermore, the levels of TNF-α and IL-6 were positively correlated with MELD score(r =0. 491, P 〈 0. 015 ; r = 0. 379, P = 0. 048 ). There was no correlation among eytokines, HBV DNA and hepatitis B surface antigen(HBsAg). Conclusions In HBV-related ACLF patients, various serum eytokines increase significantly. Furthermore, the levels of IL-6 and TNF-α increase with the severity of disease, and they are helpful in disease progression and prognosis.
出处 《检验医学》 CAS 2014年第1期26-30,共5页 Laboratory Medicine
基金 北京市自然科学基金资助项目(7111004)
关键词 细胞因子 白细胞介素6 肿瘤坏死因子Α 慢加急性肝衰竭 Cytokine Interleukin 6 Tumor necrosis factor alpha Acute-on-chronic liver failure
  • 相关文献

参考文献12

  • 1Li K,Li NL,Wei D. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like recep-tor 3 sensing of hepatitis C virus double-stranded RNA intermediates[J].{H}HEPATOLOGY,2012,(03):666-675.
  • 2叶一农,高志良.乙型肝炎肝衰竭发生机制中的三重打击[J].传染病信息,2009,22(5):276-279. 被引量:113
  • 3Graziadei IW. The clinical challenges of acute on chronic liver failure[J].{H}Liver International,2011,(03):24-26.
  • 4Martin CM,Welge JA,Shire NJ. Cytokine ex-pression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals[J].{H}CYTOKINE,2009,(03):194-198.
  • 5李子安,阿祥仁,顾玉海.高原地区慢性肺心病患者IL-6、IL-8、IL-17、IL-18含量检测及临床意义[J].检验医学,2012,27(7):617-618. 被引量:9
  • 6Kamath PS,Wiesner RH,Malinchoc M. A model to predict survival in patients with end-stage liver disease[J].{H}HEPATOLOGY,2001,(02):464-470.
  • 7González-Reimers E,Sánchez-Pérez MJ,Santolar-ia-Fernández F. Changes in cytokine levels during admission and mortality in acute alcoholic hep-atitis[J].{H}ALCOHOL,2012,(05):433-440.
  • 8梁伟,杨晖,吴春芳,余强,张大东,焦洁茹,陆国平.不同调脂治疗方案对冠心病患者血脂和IL-6、TNF-α水平的影响[J].检验医学,2011,26(3):193-197. 被引量:19
  • 9Stanley AC,Lacy P. Pathways for cytokine secretion[J].Physiology(Bethesda),2010,(04):218-229.
  • 10Mao WL,Chen Y,Chen YM. Changes of serum cytokine levels in patients with acute on chro-nic liver failure treated by plasma exchange[J].{H}Journal of Clinical Gastroenterology,2011,(06):551-555.

二级参考文献18

  • 1罗瑞虹,崇雨田,赵志新,姚集鲁.前列腺素E_1治疗重型病毒性肝炎的Meta分析[J].中山大学学报(医学科学版),2005,26(4):476-480. 被引量:7
  • 2Soresi Maurizio,Giannitrapani Lydia,D'Antona Fabio,Florena Ada Maria,La Spada Emanuele,Terranova Angela,Cervello Melchiorre,D'Alessandro Natale,Montalto Giuseppe.Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(16):2563-2568. 被引量:25
  • 3王妹芳,王龙武,邓星奇.慢性阻塞性肺疾病患者外周血及痰中IL-8、IL-17及TGF-β水平的检测和意义[J].检验医学,2007,22(4):394-397. 被引量:17
  • 4Brown BG, Zhao XQ. Importance of endothelial function in mediating the benefits of lipid-lowering therapy[ JJ. Am J Cardiol, 1998,82(10B) :49T-52T.
  • 5Williams JK, Sukhova GK, Herrington DM, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[ J]. J Am Coil Cardiol, 1998,31 ( 3 ) : 684-691.
  • 6Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [ J ]. N Engl J Med, 2004,350 (15) :1495-1504.
  • 7Waters DD, LaRosa JC, Barter P, et al. Effects of high- dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study [ J ]. J Am Coil Cardiol, 2006,48 (9) :1793-1799.
  • 8Piorkowski M, Fischer S, Stellbaum C , et al. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone : is sufficient cholesterol-lowering enough to inhibit platclets [ J ]. J Am Coil Cardiol, 2007, 49(10) :1035-1042.
  • 9Ferro D, Parrotto S, Basili S, et al. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia [ J]. J Am Coil Cardiol,2000,36(2 ) :427-531.
  • 10Kastelein JJ, Akdim F, Stroes ES, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia[ J ]. N Engl J Med, 2008,358 ( 6 ) : 1431-1443.

共引文献141

同被引文献263

引证文献26

二级引证文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部